Amgen (AMGN) EPS (Basic) (2009 - 2026)
Amgen (AMGN) posted quarterly EPS (Basic) of $3.37 for Q1 2026, up 4.76% year-over-year from $3.22 in Q1 2025, and up 35.95% quarter-over-quarter from $2.48 in Q4 2025.
Amgen (AMGN) EPS (Basic) (2009 - 2026) Analysis & Trends
Amgen's EPS (Basic) history runs 18 years deep, the most recent figure standing at $3.37 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 4.76% year-over-year to $3.37; the TTM figure through Mar 2026 stood at $14.44 (up 30.98% YoY), while the FY2025 annual figure was $14.33, up 88.18% from the prior year.
- EPS (Basic) for Q1 2026 stood at $3.37, up from $2.48 in the prior quarter.
- The five-year high for EPS (Basic) was $5.98 in Q3 2025, with the low at -$0.21 in Q1 2024.
- The 5-year median for EPS (Basic) is $2.69 (2022), against an average of $2.94.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) slumped 103.96% in 2024, then soared 1625.28% in 2025.
- Amgen's EPS (Basic) stood at $3.0 in 2022, then tumbled by 52.27% to $1.43 in 2023, then dropped by 18.56% to $1.17 in 2024, then soared by 112.2% to $2.48 in 2025, then soared by 35.95% to $3.37 in 2026.
- Business Quant data shows AMGN's EPS (Basic) at $3.37 in Q1 2026, $2.48 in Q4 2025, and $5.98 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 1.62 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 4.40 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 0.29 |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.40 |
| Mar 31, 2026 | 3.37 |
| Dec 31, 2025 | 2.48 |
| Sep 30, 2025 | 5.98 |
| Jun 30, 2025 | 2.66 |
| Mar 31, 2025 | 3.22 |
| Dec 31, 2024 | 1.17 |
| Sep 30, 2024 | 5.27 |
| Jun 30, 2024 | 1.39 |
| Mar 31, 2024 | -0.21 |
| Dec 31, 2023 | 1.43 |
| Sep 30, 2023 | 3.23 |
| Jun 30, 2023 | 2.58 |
| Mar 31, 2023 | 5.32 |
| Dec 31, 2022 | 3.00 |
| Sep 30, 2022 | 4.01 |
| Jun 30, 2022 | 2.46 |
| Mar 31, 2022 | 2.69 |
| Dec 31, 2021 | 3.33 |
| Sep 30, 2021 | 3.32 |